Clinical Trial Update: Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial at Dana-Farber Cancer Institute is evaluating Venetoclax plus chemotherapy as frontline therapy for older patients and for patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Venclexta (venetoclax)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Leukemia | Phase 1, Phase 2 | Status: RECRUITING